Literature DB >> 8156081

Dementia in Parkinson's disease.

A Friedman1, M Barcikowska.   

Abstract

The prevalence of dementia, assessed on the basis of the Wechsler scale (WAIS), was determined in a group of 88 patients with idiopathic Parkinson's disease (PD) lasting longer than 4 years. In this group, 19 patients (22%) were diagnosed as demented. They were significantly older at the time of evaluation (72.9 +/- 8.1 vs. 63.6 +/- 11.9), and also at the onset of the disease (61.1 +/- 10.6 vs. 54.4 +/- 12.1) than nondemented patients. Their parkinsonism, as judged on the base of the Activity of Daily Living Scale, was more pronounced (57.4 +/- 13.7 vs. 73.3 +/- 15.6) and they developed psychotic side-effects of L-DOPA treatment (53% vs. 9%) more often. A weak negative correlation between age and intellectual quotient (IQ) was found, and a much stronger positive correlation between education and IQ. 25 patients of those diagnosed previously as non-demented were reassessed for dementia after another 5 years of disease. Only two of them were found demented. Both died and an immunohistochemical study of their brains was performed. In the 2 cases we found neuropathological features of both PD (Lewy bodies) and Alzheimer's disease (AD)--neurofibrillary tangles (NFT) and senile plaques (SP). This finding may support the hypothesis that, at least in some cases, dementia in PD could be due to an accompanying AD.

Entities:  

Mesh:

Year:  1994        PMID: 8156081     DOI: 10.1159/000106688

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  5 in total

1.  Depression, extrapyramidal symptoms, dementia and an unexpected outcome: a case report.

Authors:  Magda Tsolaki; Chaido Z Messini; Marianna Siapera; Foteini Fotiadou; Dionysia Delaporta; Athanasios Karatolias
Journal:  Cases J       Date:  2010-02-02

2.  Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease.

Authors:  M Gold; R A Hauser; M F Chen
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

Review 3.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

4.  Mild cognitive impairment in Parkinson's disease: the challenge and the promise.

Authors:  Hubert H Fernandez; Gregory P Crucian; Michael S Okun; Catherine C Price; Dawn Bowers
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

5.  Impact of bilateral subthalamic stimulation on motor/cognitive functions in Parkinson's disease.

Authors:  Takashi Asahi; Naomi Nakamichi; Akiko Takaiwa; Daina Kashiwazaki; Masaki Koh; Nobuhiro Dougu; Shutaro Takashima; Kortaro Tanaka; Satoshi Kuroda
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-05-29       Impact factor: 1.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.